Filana Therapeutics (FLNA) Revenue (2010 - 2013)
Filana Therapeutics (FLNA) posted quarterly Revenue of $35.2 million for Q4 2013, up 1328.04% year-over-year from $2.5 million in Q4 2012, and up 1700.0% quarter-over-quarter from $2.0 million in Q3 2013.
Filana Therapeutics (FLNA) Revenue (2010 - 2013) Analysis & Trends
Filana Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $35.2 million for Q4 2013.
- In Q4 2013, Revenue rose 1328.04% year-over-year to $35.2 million; the TTM figure through Dec 2013 stood at $41.1 million (up 277.58% YoY), while the FY2013 annual figure was $41.1 million, up 277.58% from the prior year.
- Revenue for Q4 2013 stood at $35.2 million, up from $2.0 million in the prior quarter.
- The five-year high for Revenue was $35.2 million in Q4 2013, with the low at $2.0 million in Q1 2013.
- The 4-year median for Revenue is $2.7 million (2011), against an average of $5.1 million.
- The sharpest annual moves came in 2011 and 2013: Revenue tumbled 65.7% in 2011, then surged 1328.04% in 2013.
- Filana Therapeutics' Revenue stood at $8.0 million in 2010, then sank by 65.7% to $2.7 million in 2011, then fell by 10.16% to $2.5 million in 2012, then soared by 1328.04% to $35.2 million in 2013.
- Business Quant data shows FLNA's Revenue at $35.2 million in Q4 2013, $2.0 million in Q3 2013, and $2.0 million in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 674.14 Mn |
| 10 | Filana Therapeutics | 46.01 Mn | 46.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 35.24 Mn |
| Sep 30, 2013 | 1.96 Mn |
| Jun 30, 2013 | 1.96 Mn |
| Mar 31, 2013 | 1.96 Mn |
| Dec 31, 2012 | 2.47 Mn |
| Sep 30, 2012 | 2.73 Mn |
| Jun 30, 2012 | 2.72 Mn |
| Mar 31, 2012 | 2.97 Mn |
| Dec 31, 2011 | 2.75 Mn |
| Sep 30, 2011 | 2.75 Mn |
| Jun 30, 2011 | 2.75 Mn |
| Mar 31, 2011 | 3.24 Mn |
| Dec 31, 2010 | 8.01 Mn |
| Sep 30, 2010 | 2.90 Mn |
| Jun 30, 2010 | 2.66 Mn |